![Pharmaceutics | Free Full-Text | Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide Pharmaceutics | Free Full-Text | Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00816/article_deploy/html/images/pharmaceutics-13-00816-g003.png)
Pharmaceutics | Free Full-Text | Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide
![Efficacy and safety of exenatide once weekly in patients with type 2 diabetes mellitus: a post hoc analysis of pooled data from the DURATION clinical trials - Media Centre | EASD Efficacy and safety of exenatide once weekly in patients with type 2 diabetes mellitus: a post hoc analysis of pooled data from the DURATION clinical trials - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/eposters/415_494431_1/slide1.jpg)
Efficacy and safety of exenatide once weekly in patients with type 2 diabetes mellitus: a post hoc analysis of pooled data from the DURATION clinical trials - Media Centre | EASD
![These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA® (exenatide) injection, for subcutaneous useInitial U.S. Approval: 2005 These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA® (exenatide) injection, for subcutaneous useInitial U.S. Approval: 2005](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=byetta-70.jpg&id=696638)